Maxlotec, Up 19.33% on COVID-19 (Remdesivir) Theme Surge

On the 7th, the COVID-19 (Remdesivir) theme rose by 4.87% compared to the previous day, showing a strong trend, while Maxrotech, a related stock attracting attention, surged by 19.33% compared to the previous day. Maxrotech is known as a manufacturer of wired and wireless gantry robots and engine cylinder blocks for automobiles.

[Graph] Major stock price changes in the COVID-19 (Remdesivir) theme

According to preliminary data compiled at 15:21, foreign investors have purchased 26,000 shares of Maxrotech, indicating a large net buying by foreigners.

[Table] Net trading volume of foreigners and institutions (Unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Maxrotech’s quant financial score is 1.59 points, which is lower in stability, profitability, and growth compared to the average of other stocks related to COVID-19 (Remdesivir). This can be interpreted as Maxrotech having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, BC World Pharm ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.